Nuts and Olestra for Persistent Organic Pollutant Reduction (NO-POPs) Trial

NCT ID: NCT02675101

Last Updated: 2019-07-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-03-31

Study Completion Date

2019-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Persistent organic pollutants (POPs) are mostly fat-soluble halogenated chemicals with very long half-lives. POPs are endocrine disruptors, associated with increased risk for diabetes, alterations in thyroid function, and cardiovascular disease in humans. POPs concentrations increase with age because of their persistence, bioaccumulation and poor excretion. The almost ubiquitous presence of endocrine disrupting POPs in US adults is a substantial public health concern, particularly because there is no established treatment to reduce body concentrations of POPs. Most POPs are excreted in bile due to their lipophilic nature. However, a substantial amount is reabsorbed in the small intestine and returns to the blood stream (entero-hepatic circulation). The objective of this pilot study is to conduct a 6-month randomized controlled trial of Nuts and Olestra to enhance the excretion of POPs among 45 healthy adults aged 45 to 70 years with BMIs between 18-30 kg/m2. This study has 3 treatment arms: A) Whole nuts with high fat content (almonds and walnuts; 110g total/day, n=15), B) Olestra: Fat Free PringlesTM potato chips (≈29 crisps, 18g of Olestra/day; n=15), C) Vegetable oil: Original PringlesTM potato chips (≈29 crisps, 17.4g of oil/day; n=15). The investigators aim to measure change in concentrations of 24 POPs in feces after 4 days of treatment and in blood at 6 months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Persistent organic pollutants (POPs) are mostly fat-soluble halogenated chemicals with very long half-lives. POPs are endocrine disruptors, and have been associated with increased risk for diabetes, alterations in thyroid function, hypertension, dyslipidemia and neurobehavioral alterations in studies of children, and adults including the elderly. Some of the most prevalent POPs include organochlorine pesticides, polychlorinated biphenyls (PCBs) and polybrominated diphenyl ethers (PBDEs).

Most POPs are excreted in bile due to their lipophilic nature. However, a substantial amount is reabsorbed in the small intestine and returns to the blood stream (entero-hepatic circulation). Two small clinical trials found that bile acid sequestrants (cholestyramine, cholestimide) enhanced the fecal excretion of organochlorines after 2-3 days of treatment and significantly lowered their blood concentrations at 6 months. One pilot trial reported decreases in blood PCB concentrations in adults after a 1 year treatment with fat-free potato crisps made with olestra, a non-absorbable synthetic fat, versus standard potato crisps. POPs were thought to bind to olestra and be excreted in the feces. Replication of this finding is needed. Nuts, could yield similar effects. Nuts are foods with high-fat content which are incompletely absorbed in the intestine (21-24% of calorie not absorbed).

As people age, the body burdens of POPs increase. The almost ubiquitous presence of endocrine disrupting POPs in US adults is a substantial public health concern, particularly because there is no established treatment to reduce body concentrations of POPs. There is potential for dietary interventions to have an important role in the reduction of POPs at a population level due to their and low cost and wide use.

The investigators aim to measure 24 POPs (9 OC pesticides, 10 PCBs, 5 PBDEs) in blood (all participants) and in stool samples (only in a subset of 10 participants per treatment arm) before and during the treatment period. The specific aims of this pilot study are to:

1. Assess the effectiveness of recruitment strategies, acceptance and compliance of the treatment arms, and establishing the feasibility of conducting a larger trial.
2. Conduct preliminary testing of the hypotheses: Consumption of olestra (fat free Pringles): A) increases the fecal content (excretion) of POPs, and B) decreases blood levels of POPs, compared to the control arm (standard crisps).
3. Conduct preliminary testing of the hypotheses: Consumption of nuts: A) increases the fecal content (excretion) of POPs, and B) decreases blood levels of POPs, compared to the control arm (standard crisps).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Persistent Organic Pollutants Endocrine Disrupting Chemicals Endocrine Disruptor Effects

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Whole nuts

Participants will be advised on maintaining an iso-caloric diet by a Registered Dietitian. During the 6-month intervention, study subjects will consume a combination of whole almonds and walnut pieces, a total of 110 g per day. Participants will pick up supplies and be weighed 1-2 times per month for six months. Participants will also maintain a diary of their intake using an automated system. Walnuts and almonds will be provided to participants for the duration of the study.

Group Type ACTIVE_COMPARATOR

Whole Nuts

Intervention Type OTHER

Participants will be advised on maintaining an iso-caloric diet. Aside consuming nuts, the remaining composition of the prescribed diet will be based on individual preferences. During the 6-month intervention, study subjects will meet with study staff every 2-3 weeks to weigh in, pick up food supplies and complete a questionnaire on compliance. All participants will have contact with the project coordinator/study dietitian a minimum of every 1-2 weeks either in-person, telephone, email and text message contacts for support, behavioral guidance and strategies. Both walnuts and almonds will be provided to participants in the whole nut study arm.

Olestra: Fat Free Pringles

Participants will be advised on maintaining an iso-caloric diet by a Registered Dietitian. During the 6-month intervention, study subjects will consume 29 potato crisps per day, which is approximately 18 g olestra/day. Participants will pick up supplies and be weighed 1-2 times per month for six months. Participants will also maintain a diary of their intake using an automated system. Fat free Pringles will be provided to participants for the duration of the study.

Group Type EXPERIMENTAL

Olestra: Fat Free Pringles

Intervention Type OTHER

Participants will be advised on maintaining an iso-caloric diet. Aside consuming fat free potato crisps, the remaining composition of the prescribed diet will be based on individual preferences. During the 6-month intervention, study subjects will meet with study staff every 2-3 weeks to weigh in, pick up food supplies and complete a questionnaire on compliance. All participants will have contact with the project coordinator/study dietitian a minimum of every 1-2 weeks either in-person, telephone, email and text message contacts for support, behavioral guidance and strategies. Fat Free Pringles will be provided to participants in the olestra study arm.

Vegetable Oil: Original Pringles

Participants will be advised on maintaining an iso-caloric diet by a Registered Dietitian. During the 6-month intervention, study subjects will consume 29 potato crisps per day, which is approximately 17.4 g oil/day. Participants will pick up supplies and be weighed 1-2 times per month for six months. Participants will also maintain a diary of their intake using an automated system. Original Pringles will be provided to participants for the duration of the study.

Group Type PLACEBO_COMPARATOR

Vegetable Oil: Original Pringles

Intervention Type OTHER

Participants will be advised on maintaining an iso-caloric diet. Aside consuming potato crisps, the remaining composition of the prescribed diet will be based on individual preferences. During the 6-month intervention, study subjects will meet with study staff every 2-3 weeks to weigh in, pick up food supplies and complete a questionnaire on compliance. All participants will have contact with the project coordinator/study dietitian a minimum of every 1-2 weeks either in-person, telephone, email and text message contacts for support, behavioral guidance and strategies. Original Pringles will be provided to participants in the vegetable oil study arm.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Whole Nuts

Participants will be advised on maintaining an iso-caloric diet. Aside consuming nuts, the remaining composition of the prescribed diet will be based on individual preferences. During the 6-month intervention, study subjects will meet with study staff every 2-3 weeks to weigh in, pick up food supplies and complete a questionnaire on compliance. All participants will have contact with the project coordinator/study dietitian a minimum of every 1-2 weeks either in-person, telephone, email and text message contacts for support, behavioral guidance and strategies. Both walnuts and almonds will be provided to participants in the whole nut study arm.

Intervention Type OTHER

Olestra: Fat Free Pringles

Participants will be advised on maintaining an iso-caloric diet. Aside consuming fat free potato crisps, the remaining composition of the prescribed diet will be based on individual preferences. During the 6-month intervention, study subjects will meet with study staff every 2-3 weeks to weigh in, pick up food supplies and complete a questionnaire on compliance. All participants will have contact with the project coordinator/study dietitian a minimum of every 1-2 weeks either in-person, telephone, email and text message contacts for support, behavioral guidance and strategies. Fat Free Pringles will be provided to participants in the olestra study arm.

Intervention Type OTHER

Vegetable Oil: Original Pringles

Participants will be advised on maintaining an iso-caloric diet. Aside consuming potato crisps, the remaining composition of the prescribed diet will be based on individual preferences. During the 6-month intervention, study subjects will meet with study staff every 2-3 weeks to weigh in, pick up food supplies and complete a questionnaire on compliance. All participants will have contact with the project coordinator/study dietitian a minimum of every 1-2 weeks either in-person, telephone, email and text message contacts for support, behavioral guidance and strategies. Original Pringles will be provided to participants in the vegetable oil study arm.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Reside in the San Diego area
* BMI ≥18.0 kg/m2 and ≤30 kg/m2
* Non-smoker
* Willing and able to participate in clinic visits, bi-monthly supply pick-up, telephone and Internet communications at specified intervals
* Able to provide data through questionnaires and by telephone
* Willing to maintain contact with the investigators for 6 months
* Willing to allow blood collections
* Willing to provide stool samples
* No known allergy to tree nuts
* No digestive issues with olestra, chips, or nuts

Exclusion Criteria

* Nut allergies
* Smoker
* Diabetes, kidney disease or liver disease
* Concurrent acute or chronic gastro-intestinal conditions (e.g. inflammatory bowel disease, irritable bowel syndrome, concurrent diarrhea from any cause)
* Familial hypercholesterolemia
* Clotting problems or use of Coumadin,
* Inability to participate in physical activity because of severe disability
* History or presence of a co-morbid diseases for which diet modification may be contraindicated
* Self-reported pregnancy or breastfeeding or planning a pregnancy within the next year
* Currently actively involved in another diet intervention study or a weight loss program
* A history or presence of a significant psychiatric disorder or any other condition that, in the investigator's judgement, would interfere with participation in the trial
Minimum Eligible Age

45 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

San Diego State University

OTHER

Sponsor Role collaborator

University of California, San Diego

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jose R Suarez

MPH, MD, PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jose R Suarez, MPH, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University of California, San Diego

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UCSD Moores Cancer Center

La Jolla, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Contreras Lopez MC. Determination of potentially bioaccumulating complex mixtures of organochlorine compounds in wastewater: a review. Environ Int. 2003 Mar;28(8):751-9. doi: 10.1016/S0160-4120(02)00120-4.

Reference Type BACKGROUND
PMID: 12605924 (View on PubMed)

Hinck JE, Norstrom RJ, Orazio CE, Schmitt CJ, Tillitt DE. Persistence of organochlorine chemical residues in fish from the Tombigbee River (Alabama, USA): Continuing risk to wildlife from a former DDT manufacturing facility. Environ Pollut. 2009 Feb;157(2):582-91. doi: 10.1016/j.envpol.2008.08.021. Epub 2008 Oct 11.

Reference Type BACKGROUND
PMID: 18851891 (View on PubMed)

Dougherty CP, Henricks Holtz S, Reinert JC, Panyacosit L, Axelrad DA, Woodruff TJ. Dietary exposures to food contaminants across the United States. Environ Res. 2000 Oct;84(2):170-85. doi: 10.1006/enrs.2000.4027.

Reference Type BACKGROUND
PMID: 11068931 (View on PubMed)

Schafer KS, Kegley SE. Persistent toxic chemicals in the US food supply. J Epidemiol Community Health. 2002 Nov;56(11):813-7. doi: 10.1136/jech.56.11.813.

Reference Type BACKGROUND
PMID: 12388566 (View on PubMed)

Schecter A, Colacino J, Haffner D, Patel K, Opel M, Papke O, Birnbaum L. Perfluorinated compounds, polychlorinated biphenyls, and organochlorine pesticide contamination in composite food samples from Dallas, Texas, USA. Environ Health Perspect. 2010 Jun;118(6):796-802. doi: 10.1289/ehp.0901347. Epub 2010 Feb 10.

Reference Type BACKGROUND
PMID: 20146964 (View on PubMed)

Schecter A, Haffner D, Colacino J, Patel K, Papke O, Opel M, Birnbaum L. Polybrominated diphenyl ethers (PBDEs) and hexabromocyclodecane (HBCD) in composite U.S. food samples. Environ Health Perspect. 2010 Mar;118(3):357-62. doi: 10.1289/ehp.0901345. Epub 2009 Oct 28.

Reference Type BACKGROUND
PMID: 20064778 (View on PubMed)

Lee DH, Steffes MW, Sjodin A, Jones RS, Needham LL, Jacobs DR Jr. Low dose of some persistent organic pollutants predicts type 2 diabetes: a nested case-control study. Environ Health Perspect. 2010 Sep;118(9):1235-42. doi: 10.1289/ehp.0901480. Epub 2010 May 5.

Reference Type BACKGROUND
PMID: 20444671 (View on PubMed)

Lee DH, Lee IK, Jin SH, Steffes M, Jacobs DR Jr. Association between serum concentrations of persistent organic pollutants and insulin resistance among nondiabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetes Care. 2007 Mar;30(3):622-8. doi: 10.2337/dc06-2190.

Reference Type BACKGROUND
PMID: 17327331 (View on PubMed)

Patterson DG Jr, Wong LY, Turner WE, Caudill SP, Dipietro ES, McClure PC, Cash TP, Osterloh JD, Pirkle JL, Sampson EJ, Needham LL. Levels in the U.S. population of those persistent organic pollutants (2003-2004) included in the Stockholm Convention or in other long range transboundary air pollution agreements. Environ Sci Technol. 2009 Feb 15;43(4):1211-8. doi: 10.1021/es801966w.

Reference Type BACKGROUND
PMID: 19320182 (View on PubMed)

Smith D. Worldwide trends in DDT levels in human breast milk. Int J Epidemiol. 1999 Apr;28(2):179-88. doi: 10.1093/ije/28.2.179.

Reference Type BACKGROUND
PMID: 10342677 (View on PubMed)

Centers for Disease Control and Prevention. Fourth National Report on Human Exposure to Environmental Chemicals. Atlanta, GA: Centers for Disease Control and Prevention; 2009. Available at: http://www.cdc.gov/exposurereport/pdf/FourthReport.pdf.

Reference Type BACKGROUND

Eskenazi B, Chevrier J, Rauch SA, Kogut K, Harley KG, Johnson C, Trujillo C, Sjodin A, Bradman A. In utero and childhood polybrominated diphenyl ether (PBDE) exposures and neurodevelopment in the CHAMACOS study. Environ Health Perspect. 2013 Feb;121(2):257-62. doi: 10.1289/ehp.1205597. Epub 2012 Nov 15.

Reference Type BACKGROUND
PMID: 23154064 (View on PubMed)

Hsu MS, Hsu KY, Wang SM, Chou U, Chen SY, Huang NC, Liao CY, Yu TP, Ling YC. A total diet study to estimate PCDD/Fs and dioxin-like PCBs intake from food in Taiwan. Chemosphere. 2007 Apr;67(9):S65-70. doi: 10.1016/j.chemosphere.2006.05.116. Epub 2007 Jan 9.

Reference Type BACKGROUND
PMID: 17215025 (View on PubMed)

Tsutsumi T, Yanagi T, Nakamura M, Kono Y, Uchibe H, Iida T, Hori T, Nakagawa R, Tobiishi K, Matsuda R, Sasaki K, Toyoda M. Update of daily intake of PCDDs, PCDFs, and dioxin-like PCBs from food in Japan. Chemosphere. 2001 Dec;45(8):1129-37. doi: 10.1016/s0045-6535(01)00151-5.

Reference Type BACKGROUND
PMID: 11695626 (View on PubMed)

Li J, Zhang L, Wu Y, Liu Y, Zhou P, Wen S, Liu J, Zhao Y, Li X. A national survey of polychlorinated dioxins, furans (PCDD/Fs) and dioxin-like polychlorinated biphenyls (dl-PCBs) in human milk in China. Chemosphere. 2009 May;75(9):1236-42. doi: 10.1016/j.chemosphere.2009.01.073. Epub 2009 Feb 28.

Reference Type BACKGROUND
PMID: 19251302 (View on PubMed)

Polder A, Thomsen C, Lindstrom G, Loken KB, Skaare JU. Levels and temporal trends of chlorinated pesticides, polychlorinated biphenyls and brominated flame retardants in individual human breast milk samples from Northern and Southern Norway. Chemosphere. 2008 Aug;73(1):14-23. doi: 10.1016/j.chemosphere.2008.06.002. Epub 2008 Jul 23.

Reference Type BACKGROUND
PMID: 18653208 (View on PubMed)

Elobeid MA, Padilla MA, Brock DW, Ruden DM, Allison DB. Endocrine disruptors and obesity: an examination of selected persistent organic pollutants in the NHANES 1999-2002 data. Int J Environ Res Public Health. 2010 Jul;7(7):2988-3005. doi: 10.3390/ijerph7072988. Epub 2010 Jul 23.

Reference Type BACKGROUND
PMID: 20717554 (View on PubMed)

Magliano DJ, Loh VHY, Harding JL, Botton J, Shaw JE. Persistent organic pollutants and diabetes: a review of the epidemiological evidence. Diabetes Metab. 2014 Feb;40(1):1-14. doi: 10.1016/j.diabet.2013.09.006. Epub 2013 Nov 18.

Reference Type BACKGROUND
PMID: 24262435 (View on PubMed)

Ibrahim MM, Fjaere E, Lock EJ, Naville D, Amlund H, Meugnier E, Le Magueresse Battistoni B, Froyland L, Madsen L, Jessen N, Lund S, Vidal H, Ruzzin J. Chronic consumption of farmed salmon containing persistent organic pollutants causes insulin resistance and obesity in mice. PLoS One. 2011;6(9):e25170. doi: 10.1371/journal.pone.0025170. Epub 2011 Sep 23.

Reference Type BACKGROUND
PMID: 21966444 (View on PubMed)

Ibrahim MM, Fjaere E, Lock EJ, Froyland L, Jessen N, Lund S, Vidal H, Ruzzin J. Metabolic impacts of high dietary exposure to persistent organic pollutants in mice. Toxicol Lett. 2012 Nov 23;215(1):8-15. doi: 10.1016/j.toxlet.2012.09.022. Epub 2012 Oct 4.

Reference Type BACKGROUND
PMID: 23041606 (View on PubMed)

Remillard RB, Bunce NJ. Linking dioxins to diabetes: epidemiology and biologic plausibility. Environ Health Perspect. 2002 Sep;110(9):853-8. doi: 10.1289/ehp.02110853.

Reference Type BACKGROUND
PMID: 12204817 (View on PubMed)

Lee DH, Steffes MW, Sjodin A, Jones RS, Needham LL, Jacobs DR Jr. Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes. PLoS One. 2011 Jan 26;6(1):e15977. doi: 10.1371/journal.pone.0015977.

Reference Type BACKGROUND
PMID: 21298090 (View on PubMed)

Tang M, Chen K, Yang F, Liu W. Exposure to organochlorine pollutants and type 2 diabetes: a systematic review and meta-analysis. PLoS One. 2014 Oct 15;9(10):e85556. doi: 10.1371/journal.pone.0085556. eCollection 2014.

Reference Type BACKGROUND
PMID: 25329153 (View on PubMed)

Bloom MS, Jansing RL, Kannan K, Rej R, Fitzgerald EF. Thyroid hormones are associated with exposure to persistent organic pollutants in aging residents of upper Hudson River communities. Int J Hyg Environ Health. 2014 Apr-May;217(4-5):473-82. doi: 10.1016/j.ijheh.2013.09.003. Epub 2013 Sep 25.

Reference Type BACKGROUND
PMID: 24138783 (View on PubMed)

Ribas-Fito N, Cardo E, Sala M, Eulalia de Muga M, Mazon C, Verdu A, Kogevinas M, Grimalt JO, Sunyer J. Breastfeeding, exposure to organochlorine compounds, and neurodevelopment in infants. Pediatrics. 2003 May;111(5 Pt 1):e580-5. doi: 10.1542/peds.111.5.e580.

Reference Type BACKGROUND
PMID: 12728113 (View on PubMed)

Ribas-Fito N, Torrent M, Carrizo D, Munoz-Ortiz L, Julvez J, Grimalt JO, Sunyer J. In utero exposure to background concentrations of DDT and cognitive functioning among preschoolers. Am J Epidemiol. 2006 Nov 15;164(10):955-62. doi: 10.1093/aje/kwj299. Epub 2006 Sep 12.

Reference Type BACKGROUND
PMID: 16968864 (View on PubMed)

Sagiv SK, Thurston SW, Bellinger DC, Tolbert PE, Altshul LM, Korrick SA. Prenatal organochlorine exposure and behaviors associated with attention deficit hyperactivity disorder in school-aged children. Am J Epidemiol. 2010 Mar 1;171(5):593-601. doi: 10.1093/aje/kwp427. Epub 2010 Jan 27.

Reference Type BACKGROUND
PMID: 20106937 (View on PubMed)

Torres-Sanchez L, Schnaas L, Rothenberg SJ, Cebrian ME, Osorio-Valencia E, Hernandez Mdel C, Garcia-Hernandez RM, Lopez-Carrillo L. Prenatal p,p -DDE exposure and neurodevelopment among children 3.5-5 years of age. Environ Health Perspect. 2013 Feb;121(2):263-8. doi: 10.1289/ehp.1205034. Epub 2012 Nov 13.

Reference Type BACKGROUND
PMID: 23151722 (View on PubMed)

Eskenazi B, Marks AR, Bradman A, Fenster L, Johnson C, Barr DB, Jewell NP. In utero exposure to dichlorodiphenyltrichloroethane (DDT) and dichlorodiphenyldichloroethylene (DDE) and neurodevelopment among young Mexican American children. Pediatrics. 2006 Jul;118(1):233-41. doi: 10.1542/peds.2005-3117.

Reference Type BACKGROUND
PMID: 16818570 (View on PubMed)

Huang X, Lessner L, Carpenter DO. Exposure to persistent organic pollutants and hypertensive disease. Environ Res. 2006 Sep;102(1):101-6. doi: 10.1016/j.envres.2005.12.011. Epub 2006 Feb 3.

Reference Type BACKGROUND
PMID: 16458884 (View on PubMed)

Sergeev AV, Carpenter DO. Exposure to Persistent Organic Pollutants Increases Hospitalization Rates for Myocardial Infarction with Comorbid Hypertension. Prim Prev Insights. 2010 Mar 23;2:1-9. doi: 10.4137/PPRI.S4332.

Reference Type BACKGROUND
PMID: 21562627 (View on PubMed)

Lind L, Lind PM. Can persistent organic pollutants and plastic-associated chemicals cause cardiovascular disease? J Intern Med. 2012 Jun;271(6):537-53. doi: 10.1111/j.1365-2796.2012.02536.x. Epub 2012 Mar 30.

Reference Type BACKGROUND
PMID: 22372998 (View on PubMed)

Lind PM, Penell J, Salihovic S, van Bavel B, Lind L. Circulating levels of p,p'-DDE are related to prevalent hypertension in the elderly. Environ Res. 2014 Feb;129:27-31. doi: 10.1016/j.envres.2013.12.003. Epub 2014 Jan 11.

Reference Type BACKGROUND
PMID: 24528999 (View on PubMed)

Suarez-Lopez JR, Lee DH, Porta M, Steffes MW, Jacobs DR Jr. Persistent organic pollutants in young adults and changes in glucose related metabolism over a 23-year follow-up. Environ Res. 2015 Feb;137:485-94. doi: 10.1016/j.envres.2014.11.001. Epub 2015 Feb 23.

Reference Type BACKGROUND
PMID: 25706918 (View on PubMed)

Schlummer M, Moser GA, McLachlan MS. Digestive tract absorption of PCDD/Fs, PCBs, and HCB in humans: mass balances and mechanistic considerations. Toxicol Appl Pharmacol. 1998 Sep;152(1):128-37. doi: 10.1006/taap.1998.8487.

Reference Type BACKGROUND
PMID: 9772208 (View on PubMed)

Cohn WJ, Boylan JJ, Blanke RV, Fariss MW, Howell JR, Guzelian PS. Treatment of chlordecone (Kepone) toxicity with cholestyramine. Results of a controlled clinical trial. N Engl J Med. 1978 Feb 2;298(5):243-8. doi: 10.1056/NEJM197802022980504.

Reference Type BACKGROUND
PMID: 74014 (View on PubMed)

Zeng E, ed. Persistent Organic Pollutants (POPs): Analytical Techniques, Environmental Fate and Biological Effects. Elsevier Science; 2015. Available at: https://books.google.com/books?id=YCAtBAAAQBAJ&pgis=1.

Reference Type BACKGROUND

Schecter A. Dioxins and Health Including Other Persistent Organic Pollutants and Endocrine Disruptors. John Wiley & Sons; 2012. Available at: https://books.google.com/books?id=4GI2sedIls4C&pgis=1

Reference Type BACKGROUND

Mochida Y, Fukata H, Matsuno Y, Mori C. Reduction of dioxins and polychlorinated biphenyls (PCBs) in human body. Fukuoka Igaku Zasshi. 2007 Apr;98(4):106-13.

Reference Type BACKGROUND
PMID: 17533984 (View on PubMed)

Iida T, Nakagawa R, Hirakawa H, Matsueda T, Morita K, Hamamura K, Nakayama J, Hori Y, Guo YL, Chang FM, et al. Clinical trial of a combination of rice bran fiber and cholestyramine for promotion of fecal excretion of retained polychlorinated dibenzofuran and polychlorinated biphenyl in Yu-Cheng patients. Fukuoka Igaku Zasshi. 1995 May;86(5):226-33.

Reference Type BACKGROUND
PMID: 7628813 (View on PubMed)

Jandacek RJ, Heubi JE, Buckley DD, Khoury JC, Turner WE, Sjodin A, Olson JR, Shelton C, Helms K, Bailey TD, Carter S, Tso P, Pavuk M. Reduction of the body burden of PCBs and DDE by dietary intervention in a randomized trial. J Nutr Biochem. 2014 Apr;25(4):483-8. doi: 10.1016/j.jnutbio.2014.01.002. Epub 2014 Jan 29.

Reference Type BACKGROUND
PMID: 24629911 (View on PubMed)

Salas-Salvado J, Bullo M, Perez-Heras A, Ros E. Dietary fibre, nuts and cardiovascular diseases. Br J Nutr. 2006 Nov;96 Suppl 2:S46-51. doi: 10.1017/bjn20061863.

Reference Type BACKGROUND
PMID: 17125533 (View on PubMed)

Ellis PR, Kendall CW, Ren Y, Parker C, Pacy JF, Waldron KW, Jenkins DJ. Role of cell walls in the bioaccessibility of lipids in almond seeds. Am J Clin Nutr. 2004 Sep;80(3):604-13. doi: 10.1093/ajcn/80.3.604.

Reference Type BACKGROUND
PMID: 15321799 (View on PubMed)

Cassady BA, Hollis JH, Fulford AD, Considine RV, Mattes RD. Mastication of almonds: effects of lipid bioaccessibility, appetite, and hormone response. Am J Clin Nutr. 2009 Mar;89(3):794-800. doi: 10.3945/ajcn.2008.26669. Epub 2009 Jan 14.

Reference Type BACKGROUND
PMID: 19144727 (View on PubMed)

Novotny JA, Gebauer SK, Baer DJ. Discrepancy between the Atwater factor predicted and empirically measured energy values of almonds in human diets. Am J Clin Nutr. 2012 Aug;96(2):296-301. doi: 10.3945/ajcn.112.035782. Epub 2012 Jul 3.

Reference Type BACKGROUND
PMID: 22760558 (View on PubMed)

Vinson JA, Cai Y. Nuts, especially walnuts, have both antioxidant quantity and efficacy and exhibit significant potential health benefits. Food Funct. 2012 Feb;3(2):134-40. doi: 10.1039/c2fo10152a. Epub 2011 Dec 21.

Reference Type BACKGROUND
PMID: 22187094 (View on PubMed)

Hennig B, Ormsbee L, McClain CJ, Watkins BA, Blumberg B, Bachas LG, Sanderson W, Thompson C, Suk WA. Nutrition can modulate the toxicity of environmental pollutants: implications in risk assessment and human health. Environ Health Perspect. 2012 Jun;120(6):771-4. doi: 10.1289/ehp.1104712. Epub 2012 Feb 22.

Reference Type BACKGROUND
PMID: 22357258 (View on PubMed)

Lee DH, Porta M, Jacobs DR Jr, Vandenberg LN. Chlorinated persistent organic pollutants, obesity, and type 2 diabetes. Endocr Rev. 2014 Aug;35(4):557-601. doi: 10.1210/er.2013-1084. Epub 2014 Jan 31.

Reference Type BACKGROUND
PMID: 24483949 (View on PubMed)

Lee DH, Lee IK, Song K, Steffes M, Toscano W, Baker BA, Jacobs DR Jr. A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999-2002. Diabetes Care. 2006 Jul;29(7):1638-44. doi: 10.2337/dc06-0543.

Reference Type BACKGROUND
PMID: 16801591 (View on PubMed)

Lee DH, Lind PM, Jacobs DR Jr, Salihovic S, van Bavel B, Lind L. Polychlorinated biphenyls and organochlorine pesticides in plasma predict development of type 2 diabetes in the elderly: the prospective investigation of the vasculature in Uppsala Seniors (PIVUS) study. Diabetes Care. 2011 Aug;34(8):1778-84. doi: 10.2337/dc10-2116. Epub 2011 Jun 23.

Reference Type BACKGROUND
PMID: 21700918 (View on PubMed)

Zota AR, Park JS, Wang Y, Petreas M, Zoeller RT, Woodruff TJ. Polybrominated diphenyl ethers, hydroxylated polybrominated diphenyl ethers, and measures of thyroid function in second trimester pregnant women in California. Environ Sci Technol. 2011 Sep 15;45(18):7896-905. doi: 10.1021/es200422b. Epub 2011 Aug 19.

Reference Type BACKGROUND
PMID: 21830753 (View on PubMed)

Clinical and Laboratory Standards Institute. Procedures for the Collection of Diagnostic Blood Specimens by Venipuncture: Approved Standard. Sixth. (Ernst D, ed.). Wayne, Pa.: Clinical and Laboratory Standards Institute; 2007.

Reference Type BACKGROUND

Hoh E, Lehotay SJ, Mastovska K, Ngo HL, Vetter W, Pangallo KC, Reddy CM. Capabilities of direct sample introduction--comprehensive two-dimensional gas chromatography--time-of-flight mass spectrometry to analyze organic chemicals of interest in fish oils. Environ Sci Technol. 2009 May 1;43(9):3240-7. doi: 10.1021/es803486x.

Reference Type BACKGROUND
PMID: 19534141 (View on PubMed)

Hoh E, Dodder NG, Lehotay SJ, Pangallo KC, Reddy CM, Maruya KA. Nontargeted comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry method and software for inventorying persistent and bioaccumulative contaminants in marine environments. Environ Sci Technol. 2012 Aug 7;46(15):8001-8. doi: 10.1021/es301139q. Epub 2012 Jul 9.

Reference Type BACKGROUND
PMID: 22712571 (View on PubMed)

Hoh E, Lehotay SJ, Pangallo KC, Mastovska K, Ngo HL, Reddy CM, Vetter W. Simultaneous quantitation of multiple classes of organohalogen compounds in fish oils with direct sample introduction comprehensive two-dimensional gas chromatography and time-of-flight mass spectrometry. J Agric Food Chem. 2009 Apr 8;57(7):2653-60. doi: 10.1021/jf900462p.

Reference Type BACKGROUND
PMID: 19265383 (View on PubMed)

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499-502. No abstract available.

Reference Type BACKGROUND
PMID: 4337382 (View on PubMed)

Vickers AJ, Altman DG. Statistics notes: Analysing controlled trials with baseline and follow up measurements. BMJ. 2001 Nov 10;323(7321):1123-4. doi: 10.1136/bmj.323.7321.1123. No abstract available.

Reference Type BACKGROUND
PMID: 11701584 (View on PubMed)

Mattes RD, Kris-Etherton PM, Foster GD. Impact of peanuts and tree nuts on body weight and healthy weight loss in adults. J Nutr. 2008 Sep;138(9):1741S-1745S. doi: 10.1093/jn/138.9.1741S.

Reference Type BACKGROUND
PMID: 18716179 (View on PubMed)

Baer DJ, Gebauer SK, Novotny JA. Walnuts Consumed by Healthy Adults Provide Less Available Energy than Predicted by the Atwater Factors. J Nutr. 2016 Jan;146(1):9-13. doi: 10.3945/jn.115.217372. Epub 2015 Nov 18.

Reference Type BACKGROUND
PMID: 26581681 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

160096

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Impact of Phytosterol-Rich Extract on Lipid Profile
NCT06657456 ACTIVE_NOT_RECRUITING NA
Weight Loss in Pre-diabetic, Obese Women
NCT00686816 COMPLETED PHASE2